CTRI/2023/05/053277
Completed
未知
Evaluation of Skin Safety of a test product using 24 Hours Patch Test on Adult Healthy Human Participants with Sensitive Skin. IS 4011:2018 Guidelines.
Dabur Research and Development Centre.0 sites26 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dabur Research and Development Centre.
- Enrollment
- 26
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Voluntary men and women (preferably equal number of males and females) between 18
- •and 65 years having sensitive skin in nasolabial area as determined by lactic acid sting
- •2\. Participants representing normal, oily, dry and combination skin type in equal ratio.
- •3\. Fitzpatrick skin type III to IV.
- •4\. Having apparently healthy skin on test area.
- •5\. Willingness to discontinue the use of cleansing and/or cosmetic products in the application
- •areas during the course of the trial.
- •6\. Cooperating, informed of the need and duration of the examinations, and ready to comply
- •with protocol procedures.
- •7\. Willing to give written informed consent to participate in the trial after informing all
Exclusion Criteria
- •1\. Pregnancy (by UPT) and lactating women.
- •2\. Scars, excessive terminal hair, tattoo, cuts, wounds, irritation symptoms, abrasion or any
- •other skin condition on the studied area.
- •3\. Athletes and subjects with history of excessive sweating
- •4\. Subjects on oral corticosteroid
- •5\. Any history of underlying uncontrolled medical illness including diabetes, liver disease or
- •history of alcoholism, HIV or any other serious medical illness.
- •6\. A participant who the Investigator feels will not be compliant with trial requirements
- •7\. Dermatological infection/pathology on the level of studied area.
- •8\. Hypersensitivity, allergy antecedent (to any cosmetic product, raw material, hair dye).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
To study the safety of test product on skin in humans.CTRI/2022/12/048355Dabur India Limited26
Completed
Not Applicable
To study the safety of a test product on humansCTRI/2023/09/057315Dabur Research and Development Centre.26
Completed
Not Applicable
To study the safety of a test product on humans.CTRI/2023/09/057324Dabur Research and Development Centre,26
Completed
Not Applicable
To study the safety of a test product on humans.CTRI/2023/09/057319Dabur Research and Development Centre.26
Completed
Not Applicable
To study the safety of a test product on humans.CTRI/2023/09/057231Dabur Research and Development Centre,26